European Companies Search Engine

EU funding (€6,188,614): Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance. Hor1 Oct 2020 EU Research and Innovation programme "Horizon"

Overview

Text

Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance.

The novel corona virus causing COVID-19 overwhelmed Europe and the world in just a few weeks’ time. Small and Medium-sized Entrerprises (SMEs are put at very high risk by the slowdown or shutdown of economic life in their countries – exactly those companies who ensure the development of innovative solutions urgently required for counteracting the impacts of COVID-19 and for helping to control possible future outbreaks alike. In view of this situation, accelerated uptake of innovative technologies to tackle COVID-19 is most needed. In order to give an efficient and fast answer to this challenging situation, we propose building an Innovation Hub for the addressed technologies: an innovative open access platform to offer companies and reference laboratories the capabilities, expertise, networks and services required for the assessment, development, prototyping, testing, scaling-up, pilot production and market exploitation of innovative technologies to tackle COVID-19 pandemic. This approach will be based in the Open Innovation Test Beds (OITBs) concept, to incorporate lessons learned from those Innovation Actions, reducing time for putting in place such HUB and ensuring its successful implementation for a swift impact to the current situation. Our approach will include leading applied research and innovation centers in Europe, together with entities specialized in building OITBs, and reference clinical sites. INNO4COV19 will provide funding to third parties to help them achieve the desired objectives. Presence of leading applied research EU institutions in the Consortium will help to obtain a huge impact and to find and attract innovators across Europe to offer new solutions for COVID-19 pandemic and other potential future outbreaks. Europe needs to reinforce its technological leadership and rebuild an industrial sector capable to protect our citizen’s safety and well-being, and INNO4COV-19 will help in catalyzing the change.


Funded Companies:

Company name Funding amount
Acondicionamiento Tarrasense Associacion €349,255
Alma Mater Studiorum - Universita Di Bologna €100,503
Biokeralty Research Institute Aie €222,500
FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG e. V. €452,014
Fundacion Vasca de Innovacion e Investigacion Sanitarias €201,625
Instituto de Medicina Molecular Joao Lobo Antunes €440,000
International Iberian Nanotechnology Laboratory €3,507,875
Joanneum Research Forschungsgesellschaft mbH €200,001
Obelis SA €137,725
The Provost, Fellows Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin €325,000
Vlaamse Instelling Voor Technologisch Onderzoek N.V. €252,116

Source: https://cordis.europa.eu/project/id/101016203

The filing refers to a past date, and does not necessarily reflect the current state.

Creative Commons License The visualizations for "Acondicionamiento Tarrasense Associacion - EU funding (€6,188,614): Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance." are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.